Eli Lilly and CompanyLLY
Price as of · delayed, not real-time
A major U.S. pharmaceutical manufacturer focused on developing and commercializing treatments for diabetes, obesity, oncology, immunology, and neuroscience. Its recent growth has been driven by blockbuster GLP-1 drugs for diabetes and weight loss, including Mounjaro and Zepbound, which have reshaped revenue expectations across the industry. Investors closely watch the company’s drug pipeline, clinical trial outcomes, and capacity expansion as demand for metabolic disease treatments accelerates.
Congressional Interest in Eli Lilly and Company (LLY)
17 members of Congress have disclosed 381 trades in Eli Lilly and Company (LLY), a Healthcare company. The buy/sell breakdown shows 25 purchases versus 25 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading LLY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-07-10 | Dan Newhouse | sell | $1K-$15K |
| 2026-07-01 | Michael Rulli | sell | $1K-$15K |
| 2026-06-10 | Gilbert Cisneros | buy | $50K-$100K |
| 2026-06-02 | Rohit Khanna | sell | $1K-$15K |
| 2026-05-01 | Rohit Khanna | sell | $1K-$15K |
| 2026-04-14 | Gilbert Cisneros | buy | $1K-$15K |
| 2026-04-13 | Rohit Khanna | sell | $1K-$15K |
| 2026-04-08 | Elizabeth Fletcher | sell | $1K-$15K |
| 2026-04-02 | Byron Donalds | buy | $1K-$15K |
| 2026-04-02 | Byron Donalds | buy | $1K-$15K |
| 2026-03-27 | Alan Armstrong | sell | $1K-$15K |
| 2026-03-13 | Gilbert Cisneros | sell | $1K-$15K |
| 2026-02-26 | David Taylor | buy | $1K-$15K |
| 2026-02-13 | Angus S King, Jr. | sell | $1K-$15K |
| 2026-02-09 | David Taylor | sell | $1K-$15K |
| 2026-02-05 | Rohit Khanna | buy | $1K-$15K |
| 2026-01-29 | Rohit Khanna | buy | $1K-$15K |
| 2026-01-23 | Rohit Khanna | buy | $1K-$15K |
| 2026-01-16 | David Taylor | sell | $1K-$15K |
| 2026-01-02 | Michael Rulli | buy | $1K-$15K |
| 2025-12-29 | MARKWAYNE MULLIN | buy | $15K-$50K |
| 2025-12-29 | Angus S King, Jr. | buy | $1K-$15K |
| 2025-12-18 | Julie Johnson | sell | $1K-$15K |
| 2025-12-10 | David Taylor | sell | $1K-$15K |
| 2025-12-02 | Michael Rulli | sell | $1K-$15K |
| 2025-11-18 | Gilbert Cisneros | buy | $1K-$15K |
| 2025-11-13 | Julie Johnson | sell | $1K-$15K |
| 2025-11-07 | Rohit Khanna | buy | $1K-$15K |
| 2025-10-24 | Shelley M Capito | buy | $1K-$15K |
| 2025-09-25 | Rohit Khanna | buy | $1K-$15K |
| 2025-09-23 | Valerie Hoyle | sell | $1K-$15K |
| 2025-09-23 | Rohit Khanna | buy | $1K-$15K |
| 2025-08-29 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2025-08-22 | John Boozman | buy | $1K-$15K |
| 2025-08-14 | David Taylor | buy | $1K-$15K |
| 2025-08-14 | Julie Johnson | sell | $1K-$15K |
| 2025-08-14 | David Taylor | buy | $15K-$50K |
| 2025-08-12 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2025-08-11 | John Boozman | buy | $1K-$15K |
| 2025-07-24 | MICHAEL T. MCCAUL | buy | $100K-$250K |
| 2025-07-24 | MICHAEL T. MCCAUL | sell | $100K-$250K |
| 2025-07-16 | Lisa McClain | sell | $1K-$15K |
| 2025-07-10 | Lisa McClain | buy | $1K-$15K |
| 2025-06-26 | Rohit Khanna | buy | $1K-$15K |
| 2025-06-13 | MICHAEL T. MCCAUL | buy | $50K-$100K |
| 2025-06-09 | Lisa McClain | sell | $1K-$15K |
| 2025-06-03 | Jonathan Jackson | sell | $15K-$50K |
| 2025-05-30 | Gilbert Cisneros | sell | $1K-$15K |
| 2025-05-28 | Rohit Khanna | sell | $1K-$15K |
| 2025-05-21 | Jonathan Jackson | sell | $1K-$15K |